Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 11OTHER 8NETWORK 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Breast 3Thoracic 2Sarcoma 1

Conditions

Breast Neoplasms 3

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Gefitinib × Breast × Clear all
NCT00066378 2013-10-24

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
71 enrolled
Breast

Breast Neoplasms

NCT00066339 2012-07-18

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
44 enrolled
Breast

Breast Neoplasms

NCT00052169 2007-12-18

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

NSABP Foundation Inc

Phase 2 Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡